CannTrust updates on independent investigation as Health Canada continues probe
CannTrust provided an update on its independent committee’s work as the company looks to get to the bottom of how it was found to grow thousands of kilograms of unlicensed cannabis last month. The company has named the four members of its independent committee, including chair Robert Marcovitch, and outlined what the group is tasked with doing. Aside from investigating the non-compliance rating from Health Canada, the committee will make recommendations to CannTrust’s board as a result of its probe and assess any impact on the company’s assets and revenue. “The special committee takes these issues very seriously and is committed to working with Health Canada to bring the company into compliance,” said Marcovitch in a statement.